Skip to main content
Equibles

ENVESTNET ASSET MANAGEMENT INC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1407543 Berwyn, PA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,298,485
-$297,907 QoQ
Shares Held
88,755
-19.4% QoQ
Ownership
0.663%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 134 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $338,809,559 across 34 Drug Manufacturers - Specialty & Generic names. ANIK ranks #15 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HLN
Haleon plc
 6,276,154 $58,556,516
2 TEVA
Teva Pharmaceutical Industries Ltd
 1,702,176 $57,669,722
3 NBIX
Neurocrine Biosciences Inc
 262,192 $44,189,839
4 VTRS
Viatris Inc
 2,354,974 $37,396,987
5 ZTS
Zoetis Inc.
 440,465 $31,651,814
6 TAK
Takeda Pharmaceutical Co Ltd
 1,598,174 $25,618,729
7 ELAN
Elanco Animal Health Inc
 934,265 $22,992,261
8 UTHR
UNITED THERAPEUTICS Corp
 35,362 $19,160,192

All Filings in ANIK

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,298,485 88,755
2026-03-31 $1,596,392 110,096
2025-12-31 $1,132,980 117,896
2025-09-30 $1,229,604 130,809
2025-06-30 $1,284,274 121,387
2025-03-31 $1,437,379 95,634
2024-12-31 $1,137,007 69,077
2024-09-30 $1,731,939 70,119
2024-06-30 $1,923,864 75,952
2024-03-31 $1,923,796 75,740
2023-12-31 $1,765,214 77,900
2023-09-30 $1,415,917 76,002
2022-09-30 $329,487 13,844
2022-06-30 $219,740 9,845
2020-12-31 $1,363,457 30,125
2020-09-30 $943,674 26,665
2020-06-30 $835,040 22,132
2020-03-31 $601,443 20,804